Lisa DeAngelis | |
|---|---|
 | |
| Born | |
| Spouse | Peter Okin (m. 1977) |
| Academic background | |
| Education | BSc, Wellesley College MD, 1980, Columbia University Vagelos College of Physicians and Surgeons |
| Academic work | |
| Institutions | Memorial Sloan Kettering Cancer Center |
Lisa Marie DeAngelis is an American neuro-oncologist and Physician-in-Chief and Chief Medical Officer at Memorial Sloan Kettering Cancer Center.
DeAngelis was born and raised in New Haven,Connecticut to father Daniel DeAngelis. She graduated from Hopkins School and Wellesley College. [1] Following this,she earned her medical degree at the Columbia University Vagelos College of Physicians and Surgeons in 1980 and completed her fellowship in internal medicine at the NewYork-Presbyterian Hospital. [2]
Following her fellowship at the hospital,DeAngelis joined Memorial Sloan Kettering Cancer Center (MSKCC) to complete her second fellowship under the guidance of Jerome Posner. Upon completing her fellowship,she joined the faculty at MSKCC and was appointed Chair of the Department of Neurology in 1997. [3] In this role,she focused her research on the neurologic complications of cancer and led national trials of investigational drugs for primary central nervous system lymphomas. [4]
By 2012,DeAngelis was serving as Chair of the Department of Neurology and Co-Executive Director of the Brain Tumor Center. She also held the Lillian Rojtman Berkman Chair in honor of her mentor,Jerome B. Posner,and served as Vice President of the American Academy of Neurology. As a result of her accomplishments,DeAngelis was elected a Member of the National Academy of Medicine. [4] A few years later,in 2019,she was appointed the Physician-in-Chief and Chief Medical Officer of MSKCC. In this role,she was expected to oversee all clinical services,research,medical education,multi-center collaborations,and seven regional care sites across New York and New Jersey. [3]
During the COVID-19 pandemic,DeAngelis was recognized in Crain’s New York Business' 2020 Notable in Healthcare List for being "a visionary leader for the MSK community," [5] and on Avenue Magazine’s The Power List 2020. [6] In November,DeAngelis was awarded the Oligo Nation’s Lifetime Achievement Award for her leadership in the field of neuro-oncology. [7] The following year,she collabrated with David Scheinberg to establish Break Through Cancer,a foundation aimed at accelerating collaborative research,clinical trials,and cures for the deadliest cancers. [8]
DeAngelis is married to Peter Okin,a cardiology specialist. [9] They have two sons together,Daniel and Stephen. [10]
Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in the borough of Manhattan in New York City,founded in 1884 as the New York Cancer Hospital. MSKCC is one of 52 National Cancer Institute–designated Comprehensive Cancer Centers. Memorial Sloan Kettering is affiliated with Cornell University's medical school. Its main campus is located at 1275 York Avenue,between 67th and 68th streets,in Manhattan.
Monica Morrow is a breast cancer surgeon and Chief of Breast Surgery at Memorial Sloan-Kettering Cancer Center in Manhattan,NY. Her first day seeing patients in clinic as Chief at MSKCC was Tuesday,February 19,2008. She formerly served as the chairman of surgical oncology at the Fox Chase Cancer Center. She is the President-elect of the Society for Surgical Oncology.
Josep Baselga i Torres,known in Spanish as JoséBaselga was a Spanish medical oncologist and researcher focused on the development of novel molecular targeted agents,with a special emphasis in breast cancer. Through his career he was associated with the Memorial Sloan Kettering Cancer Center,Vall d'Hebron Institute of Oncology,and the Massachusetts General Hospital in their hematology and oncology divisions. He led the development of the breast cancer treatment Herceptin,a monoclonal antibody,that targets the HER2 protein which is impacted in aggressive breast cancers.
William S. Breitbart,FAPM,is an American psychiatrist in Psychosomatic Medicine,Psycho-oncology,and Palliative Care. He is the Jimmie C Holland Chair in Psychiatric Oncology,and the Chief of the Psychiatry Service,Department of Psychiatry and Behavioral Sciences,Memorial Sloan-Kettering Cancer Center,He is a Professor of Clinical Psychiatry at Weill Medical College of Cornell University. He was president of the Academy of Psychosomatic Medicine,and the Editor-in-Chief of Palliative and Supportive Care.
Hedvig Hricak was born in 1946,in Zagreb,SR Croatia,SFR Yugoslavia and earned her MD degree from the School of Medicine,University of Zagreb in 1970. She has been Chairman of the Department of Radiology,Memorial Sloan-Kettering Cancer Center since November 1999. She is professor of radiology at the Weill Medical College of Cornell University.
Jerome B. Posner is an American neurologist and co-author of Plum and Posner's Diagnosis of Stupor and Coma. Dr. Posner graduated from the University of Washington with a Bachelor of Science in 1951 and continued there to pursue a degree in medicine which was awarded in 1955.
Robert E. Wittes was Physician-in-Chief of Memorial Sloan-Kettering Cancer Center,from 2002 until December 31,2012. Prior to his appointment at MSKCC,he was Deputy Director for Extramural Sciences and Director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute,where he oversaw NCI's extramural clinical and basic research programs,including the evaluation of new therapeutics,diagnostics,and translational research. Wittes is a fellow of the American College of Physicians,a member of the American Association for Cancer Research,the American Society of Clinical Oncology,and the American Federation for Medical Research. In addition to his institutional affiliations,Dr. Wittes has served as editor-in-chief of the Journal of the National Cancer Institute and Oncology. He has served on the editorial boards of Clinical Cancer Research,Current Opinion in Oncology,The American Journal of Clinical Oncology;Cancer Investigation,and The International Journal of Radiation Oncology-Biology &Physics,among others.
George Bosl is an American cancer researcher,holder of the Patrick M. Byrne Chair in Clinical Oncology at the Memorial Sloan-Kettering Cancer Center in New York City,and is a Professor of Medicine at the Weill Cornell Medical College. In 1997 he was appointed chair of the Department of Medicine at Sloan-Kettering.
Peter T. Scardino is an American cancer surgeon,researcher,and author expert in genitourinary and urological cancers particularly cancer of the prostate. He is chair of the Department of Surgery at Memorial Sloan Kettering Cancer Center.
Kenneth Offit is an American cancer geneticist and oncologist. He is currently Chief of the Clinical Genetics Service and the Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center. Offit is also a member of the Program in Cancer Biology and Genetics at the Sloan-Kettering Institute,Professor of Medicine and Healthcare Policy and Research at Weill Cornell Medical College,and a member of both the Board of Scientific Counselors of the National Cancer Institute and the Evaluation of Genomic Applications in Practice and Prevention working group of the U.S. Centers for Disease Control.
Marcel R.M. van den Brink is a Dutch oncologist and researcher at Memorial Sloan Kettering Cancer Center known for his research in hematopoietic stem cell transplantation for cancer patients.
Jimmie Coker Holland was a founder of the field of psycho-oncology. In 1977,she worked with two colleagues to establish a full-time psychiatric service at Memorial Sloan Kettering Cancer Center. The program was one of the first of its kind in cancer treatment,and trained its psychologists to specialize in issues specific to people with cancer.
David A. Scheinberg,M.D.,Ph.D. is a physician,scientist,drug developer,and entrepreneur,who is currently Vincent Astor Chair,and Chairman of the Molecular Pharmacology Program at Memorial Sloan Kettering Cancer Center (MSK). He is a pioneer and inventor of targeted alpha particle therapies and alpha particle generators for use in patients with cancer.
Robert Maki is an American medical oncologist,Professor of Medicine at the Hospital of the University of Pennsylvania,He is a specialist in the management of and translational research regarding sarcoma,the group of connective tissue malignancies that include leiomyosarcoma,gastrointestinal stromal tumor (GIST),liposarcoma,angiosarcoma,Ewing sarcoma,desmoid tumor and many others.
Dr. Kathleen M. Foley is an American physician. She was an Attending Neurologist at Memorial Sloan-Kettering Cancer Center in New York City. She worked as a professor of Neurology,Neuroscience,and Clinical Pharmacology at Cornell University Weill Medical College. Foley made contributions toward making palliative care for cancer patients accessible. She headed the country's first pain service in a cancer center at Memorial Sloan-Kettering and was the medical director of the Supportive Care Program. In 1999,she became the director of the Open Society Institute’s Project on Death in America. Additionally,Foley was the Director of the WHO Collaborating Center for Cancer Pain Research and Education at Memorial Sloan-Kettering Cancer Center. She holds the Chair of the Society of Memorial Sloan-Kettering Cancer Center in Pain Research and continues to work with the Open Society Institute as the Medical Director of the International Palliative Care Initiative of the Network Public Health Program of the Research.
Philip W. Kantoff is a medical oncologist. He is the chairman and chief executive officer (CEO) of Convergent Therapeutics. He served as the Chairman of Medicine at Memorial Sloan Kettering Cancer Center between 2015 and 2021. He is best known for his contributions to the impact of DNA abnormalities in prostate cancer and the discovery of therapies for metastatic hormone-sensitive prostate cancer.
Rosandra N. Kaplan is an American pediatric oncologist and scientist specialized in translational and clinical research on the mechanisms of cancer spread. She is a principal investigator and head of the tumor microenvironment and metastasis branch at the National Cancer Institute.
Scott Allen Armstrong is an American pediatric oncologist and cancer biologist focused on chromatin-based control of gene expression in cancer and therapeutic discovery. Armstrong and his team were the first to isolate rare leukemia stem cells in a mouse model of leukemia.
Carol L. Brown is the Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering Cancer Center and a professor at Weill Cornell Medical College. She is a surgeon known for her work on gynecological cancers.
Aditi Sahu is a scientist working at the Memorial Sloan Kettering Cancer Centre in New York City.